Olaparib-Induced Immune-Mediated Liver Injury

Immune-mediated drug-induced liver injury can be triggered by multiple classes of medications including immunotherapies. Olaparib is a first-in-class oral inhibitor of poly (adenosine diphosphate-ribose) polymerase (an enzyme involved in DNA replication and repair) that is approved as maintenance tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Alshelleh, Mohammad, Park, Jennifer, John, Veena, Rishi, Arvind, Bernstein, David, Roth, Nitzan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751767/
https://www.ncbi.nlm.nih.gov/pubmed/35028326
http://dx.doi.org/10.14309/crj.0000000000000735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751767/
https://www.ncbi.nlm.nih.gov/pubmed/35028326
http://dx.doi.org/10.14309/crj.0000000000000735

Ejemplares similares